Johnson & Johnson said yesterday that Indian drugs authorities visited some of its facilities and it provided them with "tests and samples" of its talcum powder.
The visits come as the regulators in India launch an investigation into the US pharmaceutical company's Baby Powder, following a media report on Friday that the firm knew for decades that cancer-causing asbestos lurked in the product.
The company said the facilities were visited by the Central Drugs Standard Control Organization and some state-based food and drug administrations.
"Today, a few of our facilities were visited by the CDSCO and local FDA authorities, and we are fully cooperating with them by providing tests and samples," the J&J statement said. "The characterization of these visits as 'raids' or 'seizures; is incorrect, as has been reported in some instances. The tests have been conducted in the regular way that the FDA collects samples."
Johnson & Johnson added the safety of its cosmetic talc was based on a long history of safe use, and decades of research and clinical evidence by independent researchers and scientific review boards across the world.
It also said Indian FDAs and CDSCO have in the past confirmed its products "comply with Indian standards and are free of asbestos."
Its products are sold in some 175 countries and places, including Hong Kong.